Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Silverback Therapeutics, Inc. | President and CSO | Common Stock | 61.6K | $233K | $3.78 | May 2, 2022 | Direct |
Silverback Therapeutics, Inc. | President and CSO | Stock Option (right to buy) | 90.5K | May 2, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SPRY | Silverback Therapeutics, Inc. | May 2, 2022 | 2 | $0 | 4 | May 4, 2022 | President and CSO |
SPRY | Silverback Therapeutics, Inc. | Feb 1, 2022 | 3 | $0 | 4 | Feb 2, 2022 | President and CSO |